US WorldMeds Acquires Adaptimmune’s Cell Therapy Portfolio for $55 Million

Gibson, Dunn & Crutcher LLP has advised US WorldMeds on the transaction, and Ropes & Gray LLP has advised Adaptimmune Therapeutics plc.US WorldMeds has entered into…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here